Translations:Diabetic nephropathy/30/ja

From Azupedia
Revision as of 10:21, 27 February 2024 by Fire (talk | contribs) (Created page with "== さらに読む == {{refbegin|32em}} * {{Cite web|title = Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis|url = http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?AccessionNumber=12009100199|website = www.crd.york.ac.uk|access-date = 2015-07-02}} * {{cite journal | vauthors = Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T | title = Diabetic...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

さらに読む

  • "Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis". www.crd.york.ac.uk. Retrieved 2015-07-02.
  • Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (January 2005). "Diabetic nephropathy: diagnosis, prevention, and treatment". Diabetes Care. 28 (1): 164–76. doi:10.2337/diacare.28.1.164. PMID 15616252.
  • Tziomalos K, Athyros VG (2015). "Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis". The Review of Diabetic Studies. 12 (1–2): 110–8. doi:10.1900/RDS.2015.12.110. PMC 5397986. PMID 26676664.
  • Kume S, Koya D, Uzu T, Maegawa H (2014). "Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy". BioMed Research International. 2014: 315494. doi:10.1155/2014/315494. PMC 4122096. PMID 25126552.
  • Doshi SM, Friedman AN (August 2017). "Diagnosis and Management of Type 2 Diabetic Kidney Disease". Clinical Journal of the American Society of Nephrology. 12 (8): 1366–1373. doi:10.2215/CJN.11111016. PMC 5544517. PMID 28280116.
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Diabetic_nephropathy/30/ja&oldid=121714"